A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1 Antibody-Safety and Effectiveness o...
A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1 Antibody-Safety and Effectiveness of Pirfenidone
About this item
Full title
Author / Creator
YU, Haiming , LI, Jinying , YU, Lan , CHENG, Xi , HAN, Xiaona and ZHANG, Xiaotao
Publisher
Tianjin: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
Tianjin: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
背景与目的 免疫检查点抑制剂相关肺炎（checkpoint inhibitor pneumonitis, CIP）是严重的免疫检查点抑制剂副反应，急性期治疗手段已有共识，但急性期之后的肺间质纤维化治疗手段仍是临床需要解决的问题。方法 回顾性分析了青岛市中心医院立体定向放疗科收治的1例细胞程序性死亡受体1（programmed cell death1, PD-1）单抗导致免疫检查点抑制剂相关肺炎的非小细胞肺癌（non-small cell lung cancer, NSCLC）患者的诊断、治疗过程，并文献复习。结果 患者男性，70岁，初始诊断：左肺低分化鳞癌T3N3M0 IIIc期纵隔淋巴结转移表皮生长因子受体（epidermal growth factor receptor, EGFR）/间...
Alternative Titles
Full title
A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1 Antibody-Safety and Effectiveness of Pirfenidone
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2559451356
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2559451356
Other Identifiers
ISSN
1009-3419
E-ISSN
1999-6187
DOI
10.3779/j.issn.1009-3419.2021.103.08
